ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lilly to focus on new drugs in China, unload antibiotics brands and manufacturing facility for $375M
April 24, 2019Eli Lilly is taking one step out of China so it can gain a firmer foothold with the other. Amid a national clampdown on antibiotics overuse, the U.S. pharma is selling Chinese rights to two legacy antibiotics and a manufacturing facility in a deal worth $
Pharma Sources Insight January 2025
